CUSTOMER SUPPORT
  • Home
  • Products
  • Software
  • Lung Density Analysis™ – Functional

SaaS Software

LDAf™

Patented Parametric Response Mapping (PRM) technology

LDAf™ (Functional Lung Density Analysis) is the only fully-automated image analysis tool providing a complete mapping of normal lung, air-trapping, and areas indicative of emphysema in a combined image to visualize and quantify the components of COPD. LDAf can be useful in assessing other density-evident conditions including BOS, Asthma, and combination diseases as well.

FDA 510(k) Cleared, ARTGApproved, CE Mark Certified, Health Canada Approved

The Power of Personalized Quantitative Imaging

LDAf offers advanced density analysis for patients with COPD, Asthma, Bronchiolitis Obliterans Syndrome, and other conditions. LDAf provides maximum information for personalized care decisions as well as surgical and interventional procedure planning.

Differentiate Your Patients and Customize Their Treatments
Differentiate Your Patients and Customize Their Treatments
Here are four patients with the same standard clinical assessments. LDAf provides data to: 1. Determine what specific lung regions are affected. 2. Assess how diffuse (homogenous) or concentrated (heterogeneous) is the disease. 3. Phenotype just how much potential full - fledged emphysema there is vs. air - trapping.
LDAf-Functional-Report-5.0.png
LDAf Physician Summary Report
Advanced COPD analysis for advanced personalized care decisions. Each LDAf report includes: 1. Coronal, axial and sagittal mid-line slice visuals. 2. Quick-read bar chart of total normal lung vs. COPD sub-components. 3. Detailed quantitative data of low densities by lung regions (lung lobes or thirds optional) 4.Inspiratory and expiratory lung volumes.
Automated Inspiration-Expiration Processing
Automated Inspiration-Expiration Processing
Clear visualization of normal lung versus areas indicative of air trapping & emphysema.

For Your Practice

Lung Density Analysis™ - Functional

LDAf is a fully automated solution delivering full quantitative analysis and 3D visualization without added work for Radiology.

Suggested use cases for LDAf

    • Situations where pulmonary testing (PFT’s) are inconclusive. 
      • eg., normal PFT’s, yet symptomatic patient
    • Surgical or interventional patient selection and procedure planning. 
      • eg., fully identify the location and extent of damage, best navigational route, screen out contra-indications, etc.
    • Determining “tipping points” for changing course of care. eg., change from medical to surgical interventional care, or treating potential emphysema versus air-trapping
    • Anytime clinicians would like to more fully understand their patient – a more personalized, comprehensive picture of lung function
    • Clinical Trials and Research

      Imbio, a fully owned subsidiary of 4DMedical, is the legal manufacturer of LDAf

       

      What's new at 4DMedical

      Get the latest news about respiratory imaging and ventilation analysis
      CUSTOMER SUPPORT